SERINE PROTEASE-LIKE ACTIVITY, BUT NOT CALCIUM-INDEPENDENT PHOSPHOLIPASE A2
SERINE PROTEASE-LIKE ACTIVITY, BUT NOT CALCIUM-INDEPENDENT PHOSPHOLIPASE A2
批准号:
7954030
负责人:
Edward Franchi
金额:
$0.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-01 至 2010-01-31
关键词:
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-oneCaspase-1ChemicalsComputer Retrieval of Information on Scientific Projects DatabaseFamily memberFlagellinFundingGeneticGrantInstitutionMass Spectrum AnalysisPlayProcessResearchResearch PersonnelResourcesRoleSalmonella infectionsSerine ProteaseSourceStimulusUnited States National Institutes of Healthbasebiomedical resourcehuman PLA2G6 proteininhibitor/antagonistmicrobialpreventresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Two intracellular NLR family members, Nlc4 and Nlrp3, play a critical role in the activation of caspase-1 and release of mature IL-1b in response to specific microbial stimuli. Based on the use of chemical inhibitors, several studies have suggested an involvement of calcium-independent phospholipase A2 (iPLA2) in inflammasome activation and IL-1b secretion. Here we use pharmacological and genetic approaches to study the role of iPLA2 in the activation of caspase-1 induced through the Nlrc4 and Nlrp3 inflammasomes. Bromoenol lactone (BEL), an inhibitor that was originally used to support a role for iPLA2 in inflammasome activation, prevented caspase-1 processing induced not only by LPS and ATP, but also by Salmonella infection and cytosolic flagellin that rely on the Nlrc4 inflammasome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SERINE PROTEASE-LIKE ACTIVITY, BUT NOT CALCIUM-INDEPENDENT PHOSPHOLIPASE A2
-
批准号:8361386
-
项目类别:
-
资助金额:$1.66万
-
财政年份:2011
-
负责人:Edward Franchi
-
依托单位:
SERINE PROTEASE-LIKE ACTIVITY, BUT NOT CALCIUM-INDEPENDENT PHOSPHOLIPASE A2
-
批准号:8168781
-
项目类别:
-
资助金额:$1.13万
-
财政年份:2010
-
负责人:Edward Franchi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
壮骨止痛胶囊通过NLRP3/Caspase-1/GSDMD信号通路调控神经肽介导PMOP大鼠脑-肠-骨轴的机制研究
-
批准号:2026JJ81070
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈沙
-
依托单位:
骨痹汤调控NLRP3/ASC/Caspase-1介导的细胞焦亡治疗膝骨关节炎的作用及机制研究
-
批准号:2026JJ80380
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:郑艳艳
-
依托单位:
TIRAP调控NLRP3/Caspase-1/GSDMD通路诱导KOA软骨细胞焦亡机制的研究
-
批准号:2026JJ81783
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖杰
-
依托单位:
基于“脑肠同调”理论从NLRP3/Caspase-1/GSDMD炎症通路探讨逍遥散对肝郁脾虚型FD大鼠的作用机制
-
批准号:2026JJ80620
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贺美燕
-
依托单位:
FUNDC1介导的线粒体自噬通过ROS/NLRP3/Caspase-1调控PSD小胶质细胞焦亡的机制研究及中药干预
-
批准号:2026JJ82568
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:袁霞红
-
依托单位:
基于Caspase-1介导的焦亡探讨OSF癌变及加味丹玄口康纳米胶束干预机制
-
批准号:2026JJ81019
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李群
-
依托单位:
西维来司他钠通过抑制内皮细胞STING/caspase-1信号改善脓毒症血管高通透性的机制研究
-
批准号:2026JJ80584
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭甜
-
依托单位:
RNF31通过调控caspase-1的泛素化降解影响脓毒症诱导急性肾损伤中细 胞焦亡的机制研究
-
批准号:2025JJ50679
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邓黄浩
-
依托单位:
Prdx1通过Cathepsin B激活NLRP3/Caspase-1/GSDMD途径诱导结直肠癌细胞焦亡的作用机制研究
-
批准号:2025JJ60797
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:何影
-
依托单位:
骨髓瘤细胞外囊泡来源的RAGE通过NLRP3/caspase-1途径介导的细胞焦亡在骨髓瘤合并肌少症中的机制研究
-
批准号:2025JJ80456
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:罗平
-
依托单位: